0002160289-26-000001.txt : 20261027
0002160289-26-000001.hdr.sgml : 20261027
20261027121818
ACCESSION NUMBER: 0002160289-26-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering
ITEM INFORMATION: Investment Company Act Section 3(c)
ITEM INFORMATION: Section 3(c)(7)
FILED AS OF DATE: 20261027
DATE AS OF CHANGE: 20261027
EFFECTIVENESS DATE: 20261027
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Wellington Biomedical Innovation III Access LLC
CENTRAL INDEX KEY: 0002160289
ORGANIZATION NAME:
EIN: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-602634
FILM NUMBER: 261488790
BUSINESS ADDRESS:
STREET 1: 200 WEST STREET
CITY: NEW YORK
STATE: NY
ZIP: 10282-2198
BUSINESS PHONE: (212) 902-1000
MAIL ADDRESS:
STREET 1: 200 WEST STREET
CITY: NEW YORK
STATE: NY
ZIP: 10282-2198
D
1
primary_doc.xml
X0708
D
LIVE
0002160289
Wellington Biomedical Innovation III Access LLC
200 WEST STREET
NEW YORK
NY
NEW YORK
10282-2198
(212) 902-1000
DELAWARE
None
None
Limited Liability Company
true
2026
Jody
Flaws
c/o AURUM Governance
14425 Falconhead Blvd., Building E
Austin
TX
TEXAS
78738
Executive Officer
Manager of the Issuer's Managing Member
Scott
Huff
c/o Maples Fiduciary Svcs. (DE) Inc.
4001 Kennett Pike, Suite 302
Wilmington
DE
DELAWARE
19807
Executive Officer
Manager of the Issuer's Managing Member
Richard
A.
Ruffer
c/o Pontis Services Delaware Ltd
P.O. Box 677
Far Hills
NJ
NEW JERSEY
07931
Executive Officer
Manager of the Issuer's Managing Member
Pooled Investment Fund
Other Investment Fund
false
Decline to Disclose
- 06b
- 3C
- 3C.7
false
true
true
true
false
0
Goldman Sachs & Co. LLC
361
None
None
200 West Street
New York
NY
NEW YORK
10282-2198
All States
false
Indefinite
0
Indefinite
false
0
0
0
0
false
Wellington Biomedical Innovation III Access LLC
/s/ Richard Ruffer
Richard Ruffer
Manager of the Issuer's Managing Member
2026-10-26